In retina, the drug is the claim. You purchase the anti-VEGF agent up front, inject it, and bill afterward, so a single denied buy-and-bill claim is medication you have already paid for and cannot recover. Units by dosage, the NDC on the line, exact wastage modifiers, eye modifiers, step therapy, and authorization all have to be right. Healthcare Logic specializes in retina revenue cycle management, so the highest-risk drug claims in medicine are also your cleanest.
Retina carries the highest-risk drug claims in all of medicine. The practice buys costly anti-VEGF and complement-inhibitor agents, injects them, and bills afterward, so every coding, modifier, or authorization error is money already spent. Units billed by dosage, NDCs, wastage modifiers, eye modifiers, step therapy, and frequency edits each have to be exact, and generalist billing misses them routinely.
Because the practice purchases anti-VEGF drugs and bills them after administration, the drug is the largest dollar amount on the claim and a denial is medication already paid for. Units must be billed by the HCPCS dosage descriptor rather than the vial, the NDC is required for most commercial payers, and if the drug denies, the associated injection denies with it. Drug claims are the single highest-risk category in retina, and a wrong unit count or an off diagnosis link can cost hundreds or thousands per injection.
CPT 67028 requires an eye modifier on every injection: RT or LT for a unilateral procedure, or modifier 50 for bilateral injections on the same day, which pays at 150 percent. Claims submitted without the correct eye modifier are returned to the provider unprocessed. On a high-volume injection schedule, a missing or wrong eye modifier is a recurring, entirely preventable cause of returned claims and delayed cash.
Single-dose vial drug claims must carry the JZ modifier when there is no waste or the JW modifier with the documented discarded amount, and a single-dose drug claim missing both rejects under CMS edits. For high-cost retina agents this is a claim-level compliance failure, not a minor slip, and it is exactly the kind of workflow error that draws pre-payment denials and audit attention on the most expensive claims a retina practice files.
Many payers apply step therapy to anti-VEGF treatment, requiring a lower-cost drug before a branded agent, and most require prior authorization for the drug. On top of that, most coverage policies limit injections to no sooner than 28 days per eye, with newer drugs carrying their own FDA-label frequency. Miss the step therapy flag, the authorization, or the frequency window and the practice eats the cost of a drug it has already injected.
Healthcare Logic provides a free retina revenue audit -- identifying drug unit and NDC errors, missing eye and wastage modifiers, step therapy and authorization gaps, and frequency-edit exposure.
Healthcare Logic delivers the full revenue cycle stack adapted to intravitreal injections, anti-VEGF buy-and-bill economics, wastage and eye modifiers, retinal imaging, and the prior authorization and step therapy that govern retina revenue.
CPT 67028 coded with the mandatory RT, LT, or 50 eye modifier on every injection and modifier 25 applied correctly to a separate same-day visit -- so injection claims are never returned unprocessed for a missing or wrong modifier.
Drug lines coded with the correct J-code, units calculated from the dosage descriptor, NDC on the claim line, and diagnosis-to-dosage linkage verified -- protecting the most expensive claims a retina practice files from denial and recoupment.
JZ applied to single-dose vials with no waste and JW with the documented discarded amount on every drug line, so claims clear CMS edits and stand up to the audit scrutiny aimed at high-cost retina drugs.
Each carrier's step therapy and authorization policy tracked and cleared before the injection, with frequency edits such as the 28-day-per-eye limit checked, so the practice never injects a drug the payer will refuse to cover.
Optical coherence tomography, fundus photography, and fluorescein angiography coded with the right codes and component modifiers and reconciled against contracted allowables, so diagnostic imaging is paid in full and underpayments surface.
Front-end eligibility and benefit verification, aggressive appeals on drug and injection denials, and recoupment defense with clean wastage and authorization trails -- plus support connecting patients to affordability programs for high deductibles.
Healthcare Logic's retina workflow covers every step from authorization through recoupment defense -- keeping injection, drug, and imaging revenue accurate, compliant, and protected from the denials that turn into sunk drug cost.
No specialty punishes a billing error like retina, because the error is usually a drug the practice already bought. Buy-and-bill economics, dosage-based units, wastage modifiers, eye modifiers, and step therapy are a precise discipline. Healthcare Logic's team works inside it, turning the highest-risk drug claims in medicine into the cleanest line on the remittance.
Units by dosage, NDC on the line, and diagnosis linkage verified so the drug, the largest dollar on the claim, is never lost to a coding error.
RT, LT, or 50 on every 67028 and JZ or JW on every drug line, so claims are never returned unprocessed or rejected under CMS edits.
Each payer's step therapy, authorization, and frequency policy verified before injection, so the practice never absorbs a drug the payer refuses.
OCT, fundus photography, and angiography coded correctly and checked against contracted allowables so imaging underpayments surface.
Retina practices buy expensive anti-VEGF and complement-inhibitor drugs and bill them after administration, so the drug is the largest dollar amount on the claim and a denial means the practice has already paid for medication it cannot recover. Units must be billed by the HCPCS dosage descriptor rather than the vial, the NDC is required on the claim line for most commercial payers, and the wastage modifiers must be exact. A single coding or authorization error on a buy-and-bill claim can cost hundreds or thousands of dollars per injection, which is why drug claims are the highest-risk category in the specialty.
The administration is billed with CPT 67028, and the correct eye modifier is mandatory: RT or LT for a unilateral injection, or modifier 50 for bilateral injections on the same day. Claims submitted without an eye modifier are returned unprocessed. The drug is billed separately on its own line with the right HCPCS J-code and the number of units calculated from the dosage descriptor, and the diagnosis must support the dosage. We build all of these elements into every injection claim so it pays on the first pass.
Yes. Since the JZ modifier was mandated, single-dose vial drug claims must carry either JZ for no waste or JW for documented discarded amount, and a single-dose drug claim missing both will reject under CMS edits. For high-cost retina drugs and skin-substitute-style biologics, missing JW or JZ is a claim-level compliance failure, not a minor modifier slip. We apply the correct wastage modifier on every drug line and document discarded amounts so the claim is clean and audit-ready.
Yes. Many payers apply step therapy to anti-VEGF treatment, requiring a lower-cost drug before approving a branded agent, and most require prior authorization for the drug itself. We track each carrier's step therapy and authorization policy, flag it before the injection, and secure approval so the practice is not left holding the cost of a drug the payer will not cover. We also manage the frequency edits, commonly no sooner than 28 days per eye, that drive denials when injections are billed too close together.
Yes. We bill optical coherence tomography, fundus photography, and fluorescein angiography with the correct codes and component modifiers, and we apply modifier 25 correctly when a significant, separately identifiable office visit is performed on the same day as an injection. Weak modifier 25 documentation leads to bundling denials, so we ensure the visit is supported as distinct from the procedure rather than absorbed into it.
Talk to a Healthcare Logic retina specialist and get a free analysis of your drug claim accuracy, modifier compliance, authorization process, and imaging reimbursement.
Get a Free Retina Audit